Prediction of Biopharmaceutical Drug Disposition Classification System (BDDCS) by Structural Parameters
- PMID: 31287788
- DOI: 10.18433/jpps30271
Prediction of Biopharmaceutical Drug Disposition Classification System (BDDCS) by Structural Parameters
Abstract
Modeling of physicochemical and pharmacokinetic properties is important for the prediction and mechanism characterization in drug discovery and development. Biopharmaceutics Drug Disposition Classification System (BDDCS) is a four-class system based on solubility and metabolism. This system is employed to delineate the role of transporters in pharmacokinetics and their interaction with metabolizing enzymes. It further anticipates drug disposition and potential drug-drug interactions in the liver and intestine. According to BDDCS, drugs are classified into four groups in terms of the extent of metabolism and solubility (high and low). In this study, structural parameters of drugs were used to develop classification-based models for the prediction of BDDCS class. Reported BDDCS data of drugs were collected from the literature, and structural descriptors (Abraham solvation parameters and octanol-water partition coefficient (log P)) were calculated by ACD/Labs software. Data were divided into training and test sets. Classification-based models were then used to predict the class of each drug in BDDCS system using structural parameters and the validity of the established models was evaluated by an external test set. The results of this study showed that log P and Abraham solvation parameters are able to predict the class of solubility and metabolism in BDDCS system with good accuracy. Based on the developed methods for prediction solubility and metabolism class, BDDCS could be predicted in the correct with an acceptable accuracy. Structural properties of drugs, i.e. logP and Abraham solvation parameters (polarizability, hydrogen bonding acidity and basicity), are capable of estimating the class of solubility and metabolism with an acceptable accuracy.
Similar articles
-
Neural Network Models for Predicting Solubility and Metabolism Class of Drugs in the Biopharmaceutics Drug Disposition Classification System (BDDCS).Eur J Drug Metab Pharmacokinet. 2024 Jan;49(1):1-6. doi: 10.1007/s13318-023-00861-5. Epub 2023 Oct 21. Eur J Drug Metab Pharmacokinet. 2024. PMID: 37864650
-
BDDCS class prediction for new molecular entities.Mol Pharm. 2012 Mar 5;9(3):570-80. doi: 10.1021/mp2004302. Epub 2012 Feb 7. Mol Pharm. 2012. PMID: 22224483 Free PMC article.
-
BDDCS Predictions, Self-Correcting Aspects of BDDCS Assignments, BDDCS Assignment Corrections, and Classification for more than 175 Additional Drugs.AAPS J. 2016 Jan;18(1):251-60. doi: 10.1208/s12248-015-9845-2. Epub 2015 Nov 20. AAPS J. 2016. PMID: 26589308 Free PMC article. Review.
-
BDDCS applied to over 900 drugs.AAPS J. 2011 Dec;13(4):519-47. doi: 10.1208/s12248-011-9290-9. Epub 2011 Aug 5. AAPS J. 2011. PMID: 21818695 Free PMC article.
-
State of the Art and Uses for the Biopharmaceutics Drug Disposition Classification System (BDDCS): New Additions, Revisions, and Citation References.AAPS J. 2022 Feb 23;24(2):37. doi: 10.1208/s12248-022-00687-0. AAPS J. 2022. PMID: 35199251 Free PMC article. Review.
Cited by
-
Potential Herb-Drug Interactions in the Management of Age-Related Cognitive Dysfunction.Pharmaceutics. 2021 Jan 19;13(1):124. doi: 10.3390/pharmaceutics13010124. Pharmaceutics. 2021. PMID: 33478035 Free PMC article. Review.
-
Gabapentin: Clinical Use and Pharmacokinetics in Dogs, Cats, and Horses.Animals (Basel). 2023 Jun 20;13(12):2045. doi: 10.3390/ani13122045. Animals (Basel). 2023. PMID: 37370556 Free PMC article. Review.
-
Predicting the Drug Clearance Pathway with Structural Descriptors.Eur J Drug Metab Pharmacokinet. 2022 May;47(3):363-369. doi: 10.1007/s13318-021-00748-3. Epub 2022 Feb 11. Eur J Drug Metab Pharmacokinet. 2022. PMID: 35147854
-
Neural Network Models for Predicting Solubility and Metabolism Class of Drugs in the Biopharmaceutics Drug Disposition Classification System (BDDCS).Eur J Drug Metab Pharmacokinet. 2024 Jan;49(1):1-6. doi: 10.1007/s13318-023-00861-5. Epub 2023 Oct 21. Eur J Drug Metab Pharmacokinet. 2024. PMID: 37864650
-
Reliable Prediction of Caco-2 Permeability by Supervised Recursive Machine Learning Approaches.Pharmaceutics. 2022 Sep 21;14(10):1998. doi: 10.3390/pharmaceutics14101998. Pharmaceutics. 2022. PMID: 36297432 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical